Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verona Pharma plc - American Depositary Shares
(NQ:
VRNA
)
68.11
+0.58 (+0.87%)
Streaming Delayed Price
Updated: 12:39 PM EDT, May 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verona Pharma plc - American Depositary Shares
< Previous
1
2
3
4
Next >
4 Analysts Have This to Say About Verona Pharma
March 13, 2023
Via
Benzinga
Earnings Preview For Verona Pharma
March 06, 2023
Via
Benzinga
PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday
January 03, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.
Via
InvestorPlace
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
December 30, 2022
Via
Benzinga
20 Favorite Biotech & Medical Stocks For 2023
December 28, 2022
The way these stocks are setting up, many of them look great and will be at the forefront this coming year.
Via
Talk Markets
BTIG Maintains Buy Rating for Verona Pharma: Here's What You Need To Know
December 20, 2022
Via
Benzinga
Top-Notch Verona Pharma Scores A Win In COPD — And Hits A Four-Year High
December 20, 2022
The experimental mist reduced the risk of exacerbations in patients by 36%.
Via
Investor's Business Daily
Short Volatility Alert: Verona Pharma plc
September 22, 2022
On Wednesday, shares of Verona Pharma plc (NASDAQ: VRNA) experienced volatile short activity. After the activity, the stock price went down -0.90% to $9.96. The overall sentiment for VRNA has been...
Via
Benzinga
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
December 23, 2022
The market uptrend is under pressure.
Via
Investor's Business Daily
7 Drug Stocks That Will Soar in 2023
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 21, 2022
Via
Benzinga
Tesla, Amazon, Nike, FedEx, Verona Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today
December 20, 2022
Major Wall Street indices closed in the green on Tuesday, albeit just marginally higher, ending a four-day losing streak as investors and traders are watching out for a much anticipated year-end rally....
Via
Benzinga
HC Wainwright Raises Price For This Lung Disease Stock On First Pivotal Readout
August 29, 2022
Via
Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via
Benzinga
SINT Stock Alert: What to Know About Sintx Technologies’ Reverse Stock Split
December 20, 2022
Sintx Technologies (SINT) stock is in the news Tuesday as the company enacted a reverse stock split when markets opened this morning.
Via
InvestorPlace
Why Is Verona Pharma (VRNA) Stock Up 34% Today?
December 20, 2022
Verona Pharma (VRNA) stock is rising higher on Tuesday after the company released results from a Phase 3 clinical trial.
Via
InvestorPlace
Verona Pharma Stock Garners Investors' Attention After Successful COPD Trial
December 20, 2022
Via
Benzinga
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More
December 20, 2022
Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 20, 2022
Via
Benzinga
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 20, 2022
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday
December 20, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...
Via
Benzinga
Why You Should Invest Microcap Stocks
November 25, 2022
There’s a misperception in the market that low-priced stocks can move faster than high-priced stocks.
Via
Talk Markets
Earnings Scheduled For November 9, 2022
November 09, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
US Stock Futures Signal Higher Start On Wall Street; Bank of America Earnings In Focus
October 17, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Monday after closing lower in the previous session. The Dow Jones dropped by more than 400 points in the previous session,...
Via
Benzinga
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
October 04, 2022
Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
September 19, 2022
The biotech run off a June bottom is great — until you realize you could've netted more.
Via
Investor's Business Daily
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.